Dutch contract packager Tjoapack has selected TraceLink’s serialization solutions to help its more than 50 European pharmaceutical manufacturing customers comply with the approaching serialization deadlines for the U.S. Drug Supply Chain Security Act (DSCSA) in 2017 and the EU Falsified Medicines Directive (FMD) in 2019.

“As the market leader in the Benelux for pharmaceutical packaging and serialization, it was a natural fit to partner with TraceLink,” said Eric Tjoa, chief executive officer, Tjoapack. “Their Life Sciences Cloud allows us to provide our customers a cost-effective and agile track and trace solution, well ahead of the U.S. and EU deadlines, while continuing to guarantee we deliver the highest quality of services. We offer both standard and bespoke solutions to our customers and only TraceLink has been able to accommodate the tailored data needs associated with the nature of our business.”

“The industry is beginning to place greater attention on EU FMD compliance, which introduces new complexities in serialization and government reporting. As a result, TraceLink is experiencing rapid customer adoption in Europe as companies realize that the proven Life Sciences Cloud platform provides them with an easy and fast path directly into the EU Hub,” said Shabbir Dahod, president and chief executive officer, TraceLink. “Tjoapack values our deep expertise on EU compliance and chose TraceLink to help achieve multiple country regulations for serialization, keep costs low and meet the complex data demands of their customers whether they have to comply with DSCSA, EU FMD, or both.”